Omega Healthcare Investors (NYSE:OHI) Posts Quarterly Earnings Results, Misses Estimates By $0.20 EPS

Omega Healthcare Investors (NYSE:OHI) released its quarterly earnings results on Tuesday. The real estate investment trust reported $0.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.20), FiscalAI reports. Omega Healthcare Investors had a net margin of 58.11% and a return on equity of 13.82%. The firm had revenue of $340.55 million for the quarter, compared to the consensus estimate of $269.16 million. During the same quarter in the prior year, the firm earned $0.79 earnings per share. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year.

Omega Healthcare Investors Trading Down 2.1%

Shares of OHI traded down $1.02 during midday trading on Thursday, reaching $48.15. 798,721 shares of the stock were exchanged, compared to its average volume of 2,071,143. The company has a market capitalization of $14.59 billion, a P/E ratio of 19.40, a PEG ratio of 1.92 and a beta of 0.56. Omega Healthcare Investors has a 52 week low of $41.53 and a 52 week high of $52.39. The company’s 50 day moving average is $46.23 and its two-hundred day moving average is $46.65.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Thursday, November 5th will be given a dividend of $0.68 per share. The ex-dividend date of this dividend is Thursday, November 5th. This represents a $2.72 dividend on an annualized basis and a dividend yield of 5.6%. Omega Healthcare Investors’s dividend payout ratio is presently 97.14%.

Analyst Upgrades and Downgrades

Several brokerages have commented on OHI. Wall Street Zen upgraded shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating in a research note on Saturday, October 17th. Cantor Fitzgerald upped their target price on shares of Omega Healthcare Investors from $52.00 to $56.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. Raymond James Financial reaffirmed an “outperform” rating and issued a $53.00 price objective on shares of Omega Healthcare Investors in a research note on Tuesday, October 6th. Weiss Ratings restated a “buy (b+)” rating on shares of Omega Healthcare Investors in a report on Friday, September 25th. Finally, UBS Group reduced their price target on Omega Healthcare Investors from $54.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, October 13th. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, Omega Healthcare Investors has a consensus rating of “Hold” and a consensus target price of $49.93.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust focused on the healthcare sector. The company invests in and owns healthcare facilities, with a primary emphasis on skilled nursing and assisted living properties.

Omega generally leases its properties to healthcare operators under long-term agreements, supporting services for seniors and individuals who require post-acute, rehabilitative, or long-term care. Its portfolio has also included other healthcare-related properties, such as continuing care retirement communities and specialty facilities.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega serves healthcare operators across the United States and the United Kingdom.